• "Como que, como que? como que?" Single-language echolalia in a bilingual female with progressive supranuclear palsy: a case report
• A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy
• A Short Progressive Supranuclear Palsy Quality of Life Scale
• Absolute quantitation of sympathetic nerve activity using [¹²³I] metaiodobenzylguanidine SPECT-CT in neurology
• Added value of FDG-PET for detection of progressive supranuclear palsy
• An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders
• An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration
• Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies
• Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy
• Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review
• Assessment of [¹⁸F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function
• Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
• Behavioral and histological analyses of the mouse <em>Bassoon</em> p.P3882A mutation corresponding to the human <em>BSN</em> p.P3866A mutation
• Brain Proteome Profiling Reveals Common and Divergent Signatures in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
• Candidate GRN Variant in Patient With Progressive Supranuclear Palsy
• Case Report: Benefits of LSVT LOUD in a multilingual patient with hypokinetic-hyperkinetic dysarthria and suspected progressive supranuclear palsy
• Circular walking is useful for assessing the risk of falls in early progressive supranuclear palsy
• Clinical Manifestations
• Clinical utility of square-wave jerks in neurology and psychiatry
• Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease
• Clonic Perseveration in Neurodegenerative Parkinsonism
• Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
• Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy
• Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study
• CSF Proteomics in Patients With Progressive Supranuclear Palsy
• Determinants of care partner burden in atypical Parkinsonian syndromes: A retrospective, multi-center analysis
• Diagnostic Performance of ASL-MRI and FDG-PET in Frontotemporal Dementia: A Systematic Review and Meta-Analysis
• Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging
• DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation
• Dopa-responsive Rest Tremor Preceding Tachyphemia in Progressive Supranuclear Palsy: A Case Report
• Ethnic Differences in Atypical Parkinsonism-is South Asian PSP Different?
• Evaluating the efficacy of few-shot learning for GPT-4Vision in neurodegenerative disease histopathology: A comparative analysis with convolutional neural network model
• Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study
• Expanding the Spectrum of GBA1-Associated Neurodegenerative Diseases in an Italian Family
• Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis
• Foreword: Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies
• Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival of <em>MAPT</em> Mutation iPSC-derived Neurons
• Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
• Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia
• Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
• Impaired sequence manipulation in non-demented patients with progressive supranuclear palsy
• In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy
• Incidence of Primary Progressive Apraxia of Speech and Primary Progressive Aphasia in Olmsted County, MN, 2011-2022
• Induction of tau pathology and motor dysfunction in mice by urinary exosomes from progressive supranuclear palsy patients
• Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies
• Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study
• Late-life mood disorder as the initial presentation of progressive supranuclear palsy: A case series
• Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy
• Low-intensity vestibular noise stimulation improves postural symptoms in progressive supranuclear palsy
• Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials
• MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
• Meta-analysis of the association between <em>C9orf72</em> repeats and neurodegeneration diseases
• Minimal Detectable Change of Cough and Lingual Strength Outcomes in Neurodegenerative Disease
• Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life
• Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change
• Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
• Nature of Parkinsonian features in multiple system atrophy
• Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers
• Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism
• Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
• Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms
• Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
• Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum
• Peripheral immune profile and neutrophil-to-lymphocyte ratio in progressive supranuclear palsy: Case-control study and meta-analysis
• Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
• Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome
• Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
• Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
• Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada
• Progressive Supranuclear Palsy Diagnosed After a Severe Fall Trauma in a Patient Who Experienced Episodes of Easy Falling
• Progressive Supranuclear Palsy Syndrome: An Overview
• Progressive supranuclear palsy, a case report
• Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies
• Progressive Supranuclear Palsy: Subcortical Tau Depositions Are Associated with Cortical Perfusion in Frontal and Limbic Regions
• Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
• Proteomic networks of gray and white matter reveal tissue-specific changes in human tauopathy
• Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)
• Radiomics-Guided Deep Learning Networks Classify Differential Diagnosis of Parkinsonism
• Rapid Eye Movements during REM Sleep Differentiate PSP from Parkinson's Disease
• Seeing without a Scene: Neurological Observations on the Origin and Function of the Dorsal Visual Stream
• Serum Oligomeric alpha-Synuclein and p-tau181 in Progressive Supranuclear Palsy and Parkinson's Disease
• SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy
• Stepwise Functional Brain Architecture Correlates with Atrophy in Progressive Supranuclear Palsy
• Structural parameters are superior to eigenvector centrality in detecting progressive supranuclear palsy with machine learning & multimodal MRI
• Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies
• Supranuclear Palsy as an Initial Presentation of the Adult-Onset Niemann-Pick Type C
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
• Systematic assessment of square-wave jerks in progressive supranuclear palsy: a video-oculographic study
• Tau protein profiling in tauopathies: a human brain study
• Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
• The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy
• The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study
• The potential significance of hepcidin evaluation in progressive supranuclear palsy
• The Role of MicroRNAs in Progressive Supranuclear Palsy-A Systematic Review
• TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy
• Transcriptional expression patterns of the cortical morphometric similarity network in progressive supranuclear palsy
• Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study
• Usefulness of Olfactory Bulb Measurement in 3D-FIESTA in Differentiating Parkinson Disease from Atypical Parkinsonism
• Voxel-Based Morphometry of Progressive Supranuclear Palsy Using a 3D Fast Low-angle Shot Localizer Image: A Comparison with Magnetization-Prepared Rapid Gradient Echo
• Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy